Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in JAMA Retrieve available abstracts of 66 articles: HTML format

Single Articles

November 2021
1. NACHTIGALL M, Nachtigall RH
   The Role of Lipoprotein(a) in Cardiovascular Diseases.
   JAMA. 2021;326:2078.
   PubMed    
   
   
   
2. NATARAJAN P, Miksenas H, Januzzi JL Jr
   The Role of Lipoprotein(a) in Cardiovascular Diseases-Reply.
   JAMA. 2021;326:2078-2079.
   PubMed    
   
   
   
3. SLOMSKI A
   Intensive Blood Pressure Control Lowers Cardiovascular Risk.
   JAMA. 2021;326:2001.
   PubMed    
   
   
   
4. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
   Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
   JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
   PubMed    
   
   
   
5. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
   Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
   JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
   PubMed     Abstract available
   
   
   
6. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
   Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
   JAMA. 2021;326:1818-1828.
   PubMed     Abstract available
   
   
   
7. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
   Cardiogenic Shock After Acute Myocardial Infarction: A Review.
   JAMA. 2021;326:1840-1850.
   PubMed     Abstract available
   
   
   
8. BRAVO PE, Cappola TP
   Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
   JAMA. 2021;326:1803-1804.
   PubMed    
   
   
   October 2021
9. SAAD M, Kennedy KF, Imran H, Louis DW, et al
   Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction.
   JAMA. 2021 Oct 29. pii: 2785893. doi: 10.1001/jama.2021.18890.
   PubMed     Abstract available
   
   
   
10. FANAROFF AC, Garcia S, Giri J
    Myocardial Infarction During the COVID-19 Pandemic.
    JAMA. 2021 Oct 29. pii: 2785894. doi: 10.1001/jama.2021.19608.
    PubMed    
    
    
    
11. HE J, Zhu Z, Bundy JD, Dorans KS, et al
    Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    JAMA. 2021;326:1286-1298.
    PubMed     Abstract available
    
    
    September 2021
12. ZUIN M, Rigatelli G, Zuliani G
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults.
    JAMA. 2021;326:1212-1213.
    PubMed    
    
    
    
13. WHITLOCK EL, Glymour MM
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults-Reply.
    JAMA. 2021;326:1213.
    PubMed    
    
    
    August 2021
14. 
    Worse Cardiovascular Outcomes Found in Disadvantaged Areas.
    JAMA. 2021;326:591.
    PubMed    
    
    
    July 2021
15. SLOMSKI A
    Fewer Cardiovascular Events With Intensive Blood Pressure Control.
    JAMA. 2021;326:299.
    PubMed    
    
    
    
16. WILKINS JT, Lloyd-Jones DM
    Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    JAMA. 2021;326:266-267.
    PubMed    
    
    
    
17. MIKSENAS H, Januzzi JL Jr, Natarajan P
    Lipoprotein(a) and Cardiovascular Diseases.
    JAMA. 2021 Jul 8. pii: 2781946. doi: 10.1001/jama.2021.3632.
    PubMed    
    
    
    June 2021
18. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    PubMed    
    
    
    
19. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    PubMed    
    
    
    
20. SOLOMON MD, Nguyen-Huynh M, Leong TK, Alexander J, et al
    Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges.
    JAMA. 2021 Jun 2. pii: 2780794. doi: 10.1001/jama.2021.8414.
    PubMed    
    
    
    May 2021
21. GOTTESMAN RF, Johansen MC
    Coronary Revascularization and Cognitive Decline: The Patient or the Procedure?
    JAMA. 2021;325:1941-1942.
    PubMed    
    
    
    
22. OGATA H, Fukagawa M, Hirakata H, Kagimura T, et al
    Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    JAMA. 2021;325:1946-1954.
    PubMed     Abstract available
    
    
    
23. WHITLOCK EL, Diaz-Ramirez LG, Smith AK, Boscardin WJ, et al
    Association of Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention With Memory Decline in Older Adults Undergoing Coronary Revascularization.
    JAMA. 2021;325:1955-1964.
    PubMed     Abstract available
    
    
    
24. JOSHI PH, de Lemos JA
    Diagnosis and Management of Stable Angina: A Review.
    JAMA. 2021;325:1765-1778.
    PubMed     Abstract available
    
    
    April 2021
25. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    
    
    
    
26. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    
    
    
    
27. ANCHAN R, Cifu AS, Paul J
    Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation.
    JAMA. 2021;325:1556-1557.
    PubMed    
    
    
    
28. RIGATELLI G, Zuin M
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2021;325:1565.
    PubMed    
    
    
    
29. SUD M, Fang J, Ko DT
    Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease-Reply.
    JAMA. 2021;325:1565-1566.
    PubMed    
    
    
    
30. KAMRAN H, Jneid H, Kayani WT, Virani SS, et al
    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.
    JAMA. 2021;325:1545-1555.
    PubMed     Abstract available
    
    
    
31. WANG Y
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    
    
    
    
32. OLSHANSKY B, Bhatt DL, Chung MK
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1332-1333.
    PubMed    
    
    
    
33. PARK KY, Park HK, Hwang HS
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1334.
    PubMed    
    
    
    
34. WELTY F, Bistrian B, Driscoll D
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk.
    JAMA. 2021;325:1333.
    PubMed    
    
    
    
35. NISSEN SE, Lincoff AM, Nicholls SJ
    Omega-3 Fatty Acids Effect on Major Cardiovascular Events in Patients at High Cardiovascular Risk-Reply.
    JAMA. 2021;325:1334-1335.
    PubMed    
    
    
    March 2021
36. SLOMSKI A
    Polypill Plus Aspirin Effective for Cardiovascular Disease Prevention.
    JAMA. 2021;325:1135.
    PubMed    
    
    
    
37. FRIEDEN TR, Foti KE
    National Initiatives to Prevent Myocardial Infarction and Stroke.
    JAMA. 2021 Mar 12. pii: 2777651. doi: 10.1001/jama.2021.0905.
    PubMed    
    
    
    
38. YOU SC, Gupta A, Krumholz HM
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention-Reply.
    JAMA. 2021;325:890-891.
    PubMed    
    
    
    
39. KIM HK, Kubica J, Jeong YH
    Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention.
    JAMA. 2021;325:890.
    PubMed    
    
    
    February 2021
40. KOLTE D, Libby P, Jang IK
    New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes.
    JAMA. 2021 Feb 22. pii: 2776938. doi: 10.1001/jama.2021.0069.
    PubMed    
    
    
    
41. PERAK AM, Lancki N, Kuang A, Labarthe DR, et al
    Associations of Maternal Cardiovascular Health in Pregnancy With Offspring Cardiovascular Health in Early Adolescence.
    JAMA. 2021;325:658-668.
    PubMed     Abstract available
    
    
    
42. DANIELS SR
    Maternal Cardiovascular Health: A Critical Period for Offspring Lifetime Cardiovascular Health?
    JAMA. 2021;325:630-631.
    PubMed    
    
    
    
43. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    PubMed     Abstract available
    
    
    
44. KHATANA SAM, Venkataramani AS, Nathan AS, Dayoub EJ, et al
    Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults.
    JAMA. 2021;325:445-453.
    PubMed     Abstract available
    
    
    
45. WEEKS WB, Weinstein JN
    Economic Prosperity and Cardiovascular Mortality: Further Evidence That All Policy Is Health Policy.
    JAMA. 2021;325:439-440.
    PubMed    
    
    
    January 2021
46. LOPES RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, et al
    Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
    JAMA. 2021;325:254-264.
    PubMed     Abstract available
    
    
    December 2020
47. SLOMSKI A
    Empagliflozin Cuts Cardiovascular Deaths in Advanced Heart Failure.
    JAMA. 2020;324:2476.
    PubMed    
    
    
    
48. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available
    
    
    
49. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    PubMed    
    
    
    
50. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    PubMed     Abstract available
    
    
    November 2020
51. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2069-2075.
    PubMed     Abstract available
    
    
    
52. O'CONNOR EA, Evans CV, Rushkin MC, Redmond N, et al
    Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;324:2076-2094.
    PubMed     Abstract available
    
    
    
53. JIN J
    Counseling on Healthy Diet and Physical Activity to Prevent Cardiovascular Disease.
    JAMA. 2020;324:2114.
    PubMed    
    
    
    
54. SMILOWITZ NR, Berger JS
    Cardiovascular Risk Assessment for Noncardiac Surgery-Reply.
    JAMA. 2020;324:2106-2107.
    PubMed    
    
    
    
55. GRASSHOFF C, Magunia H
    Cardiovascular Risk Assessment for Noncardiac Surgery.
    JAMA. 2020;324:2105-2106.
    PubMed    
    
    
    
56. KHAN SS, Greenland P
    Comprehensive Cardiovascular Health Promotion for Successful Prevention of Cardiovascular Disease.
    JAMA. 2020;324:2036-2037.
    PubMed    
    
    
    
57. SHARMA G, Martin SS, Blumenthal RS
    Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events: What Matters Most: the Drug, the Dose, or the Placebo?
    JAMA. 2020 Nov 15. pii: 2773118. doi: 10.1001/jama.2020.22387.
    PubMed    
    
    
    
58. NICHOLLS SJ, Lincoff AM, Garcia M, Bash D, et al
    Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
    JAMA. 2020 Nov 15. pii: 2773120. doi: 10.1001/jama.2020.22258.
    PubMed     Abstract available
    
    
    
59. SUD M, Han L, Koh M, Austin PC, et al
    Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
    JAMA. 2020 Nov 13. pii: 2773127. doi: 10.1001/jama.2020.22708.
    PubMed     Abstract available
    
    
    
60. BACH RG
    Physiology-Based Revascularization Decisions and Improved Clinical Outcomes Following Percutaneous Coronary Interventions.
    JAMA. 2020 Nov 13. pii: 2773126. doi: 10.1001/jama.2020.22998.
    PubMed    
    
    
    October 2020
61. SLOMSKI A
    Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease.
    JAMA. 2020;324:1599.
    PubMed    
    
    
    
62. BATES ER
    Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes.
    JAMA. 2020;324:1613-1615.
    PubMed    
    
    
    
63. YOU SC, Rho Y, Bikdeli B, Kim J, et al
    Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    JAMA. 2020;324:1640-1650.
    PubMed     Abstract available
    
    
    June 2020
64. HADAYA J, Benharash P
    Extracorporeal Membrane Oxygenation.
    JAMA. 2020;323:2536.
    PubMed    
    
    
    May 2020
65. HIRSCH IB, Gaudiani LM
    Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    JAMA. 2020 May 22. pii: 2766597. doi: 10.1001/jama.2020.1303.
    PubMed    
    
    
    February 2020
66. THIELE H, Desch S, Freund A
    Microaxial Left Ventricular Assist Devices: In Search of an Appropriate Indication.
    JAMA. 2020;323:716-718.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: